Showing results (301-310 of 378) with videos related to

Sort By:
Pageof 38
Blood|September 1, 1996
Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosisA H Sarris, R Luthra, V Papadimitracopoulou, et al.
British Journal of Cancer|February 21, 2013
High MET expression is an adverse prognostic factor in patients with triple-negative breast cancerF Zagouri, Z Bago-Horvath, F Rössler, et al.
Leukemia|November 28, 2012
Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic diseaseE Kastritis, E Terpos, L Moulopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosisA H Sarris, R Luthra, V Papadimitracopoulou, et al.
BMC Urology|June 4, 2020
Axitinib as a third or further line of treatment in renal cancer: a single institution experienceG Tsironis, M Liontos, A Kyriazoglou, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2011
Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factorA Bamias, M Sotiropoulou, F Zagouri, et al.
Blood Cancer Journal|May 28, 2016
Increased circulating VCAM-1 correlates with advanced disease and poor survival in patients with multiple myeloma: reduction by post-bortezomib and lenalidomide treatmentE Terpos, M Migkou, D Christoulas, et al.
Annals of Internal Medicine|September 1, 1980
Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphomaJ U Gutterman, G R Blumenschein, R Alexanian, et al.
Oncology|September 20, 2002
Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trialsC Bacoyiannis, M A Dimopoulos, H P Kalofonos, et al.
American Journal of Hematology|June 1, 1994
Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiationM A Dimopoulos, J C Yau, S D Huan, et al.
Pageof 38